HALO logo
halo search icon
4519
Chugai Pharmaceutical Co., Ltd.

4519 · Chugai Pharmaceutical Co., Ltd.

7011.00

JPY
-90.00 (-1.267%)
21/08/2026 12:00:00 AM
+1
Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

JPY11.92T

PE

31.30

EV/EBITDA

20.2

DIV Yield

3.3%

Payout Ratio

103%

MQV Rating

4Weak

As at 21/08/2026 12:00:00 AM

Price Chart

Description

Chugai Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals. Its operations are carried out through the Domestic and Overseas businesses. The Domestic business covers the manufacturing, research, and development operations in Japan. The Overseas business comprises of sales and production in Europe, Taiwan and China. The company was founded by Juzo Ueno on March 10, 1925 and is headquartered in Tokyo, Japan.

  • All-Companies
  • All-Consensus
  • Consensus Cheap
  • HALO 200
  • HALO 500
  • HALO All
  • HALO Balance Sheet
  • HALO Capital Efficiency
  • HALO Consensus Value

Key Fundamentals

EPS 3 yr Growth

15.90%

EBITDA Margin

49.60%

Operating Cashflow

¥389,451m

Free Cash Flow Return

19.70%

ROIC

22.00%

Interest Coverage

NaN

Quick Ratio

3.60

Performance

52 weeks range

Low 6002 - 10700

Trade Value (12mth)

US$32,802,384.00

1 week

-1.03%

1 month

-2.81%

YTD

-16.62%

1 year

16.56%

All time high

10700.00

Additional Data

Shares Outstanding (Fully Diluted)

1,646m

HALO Sector

Healthcare

Next Company Report Date

04-Feb-27

Next Ex Dividend Date

29-Dec-26

Next Dividend Pay Date

29-Dec-26

Reporting Currency

JPY

Short Sell (% of issue)

0.00

Consensus score

Lock Icon/10

Recommendation

Buy

Target price

Lock Icon

Deviation

Lock Icon

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

Mqv

Weak

Garp

Strong

Mqv Small

Neutral

Momentum

Price

Very Weak

Earnings

Very Weak

Growth

Earnings

Neutral

Dividends

Weak

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

Value

Lock Icon

Consensus

Lock Icon

Yield

Lock Icon

News & Announcements

No announcements available.

Key Stakeholders

NameTitle
Roche Holding AGPublic Company
Chugai Pharmaceutical Co., Ltd.Public Company
Sumitomo Life Insurance Co.Private Company
Tokio Marine Holdings, Inc.Public Company
Sompo Holdings, Inc.Public Company

See beyond the curve.

One solution for research, investing and portfolio management.
Want to learn more?Frequently asked questions.
1
What is the current share price of Chugai Pharmaceutical Co., Ltd. (4519:TKS)?
Halo FAQ
The current share price of Chugai Pharmaceutical Co., Ltd. (4519:TKS) is JPY¥7011.00.
2
What is the 52-week high share price for Chugai Pharmaceutical Co., Ltd. (4519:TKS)?
Halo FAQ
The 52-week high share price for Chugai Pharmaceutical Co., Ltd. (4519:TKS) is JPY¥10700.00.
3
What is the 52-week low share price for Chugai Pharmaceutical Co., Ltd. (4519:TKS)?
Halo FAQ
The 52-week low share price for Chugai Pharmaceutical Co., Ltd. (4519:TKS) is JPY¥6002.00.
4
What is the dividend yield for Chugai Pharmaceutical Co., Ltd. (4519:TKS)?
Halo FAQ
The current TTM dividend payout for Chugai Pharmaceutical Co., Ltd. (4519:TKS) is 3.30.
5
What was Chugai Pharmaceutical Co., Ltd. (4519:TKS) last dividend payment?
Halo FAQ
The last dividend payment of Chugai Pharmaceutical Co., Ltd. (4519:TKS) is JPY¥0.66.
6
What is the franking level for Chugai Pharmaceutical Co., Ltd. (4519:TKS)?
Halo FAQ
Chugai Pharmaceutical Co., Ltd. (4519:TKS) has a franking level of 0.00%.
7
In which sector is Chugai Pharmaceutical Co., Ltd. (4519:TKS) classified?
Halo FAQ
Chugai Pharmaceutical Co., Ltd. (4519:TKS) is classified in the Healthcare.
8
What is the price-to-earnings (P/E) ratio for Chugai Pharmaceutical Co., Ltd. (4519:TKS)?
Halo FAQ
The current P/E ratio for Chugai Pharmaceutical Co., Ltd. (4519:TKS) is 31.30.